Search Results - "Zhu, Hanzhang"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression by Zhu, Hanzhang, Zhou, Weijiang, Wan, Yafeng, Lu, Jun, Ge, Ke, Jia, Changku

    “…Pancreatic cancer is one of the most lethal malignant tumors. However, the molecular mechanisms responsible for its progression are little known. This study…”
    Get full text
    Journal Article
  2. 2

    Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway by Zhu, Hanzhang, Wang, Jingrui, Yin, Junjie, Lu, Bei, Yang, Qijun, Wan, Yafeng, Jia, Changku

    Published in Cellular physiology and biochemistry (01-01-2018)
    “…Background/Aims: The expression of PRAME and its role in hepatocellular carcinoma (HCC) remain unknown. The aim of this study was to examine the functional…”
    Get full text
    Journal Article
  3. 3

    Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease by Zhu, Hanzhang, Ge, Ke, Lu, Jun, Jia, Changku

    Published in Gut and liver (01-07-2020)
    “…Background/AimsThe pathogenesis of nonalcoholic fatty liver disease (NAFLD) has not be fully elucidated, and the lack of therapeutic strategies for NAFLD is an…”
    Get full text
    Journal Article
  4. 4

    Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy by Zhu, Hanzhang, Zhou, Weijiang, Wan, Yafeng, Ge, Ke, Lu, Jun, Jia, Changku

    Published in Cancer nanotechnology (01-12-2020)
    “…Background The present study aims to develop a nanoparticle encapsulating doxorubicin (DOX) and programmed death-ligand 1 (PD-L1) siRNA and evaluate its…”
    Get full text
    Journal Article
  5. 5

    Resveratrol protects against chronic alcohol-induced liver disease in a rat model by Zhu, Hanzhang, Lu, Jun, Zhou, Weijiang, Jia, Changku

    Published in STEMedicine (02-07-2022)
    “…Hepatic ethanol metabolism participates in the pathogenesis of alcoholic liver disease (ALD). We aimed to evaluate the protecting effects and underlying…”
    Get full text
    Journal Article
  6. 6

    Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN by Zhu, Hanzhang, Liu, Qiaoyu, Tang, Junwei, Xie, Yu, Xu, Xiaoliang, Zhang, Yuanguangyan, Jin, Kangpeng, Sun, Beicheng

    Published in Cellular physiology and biochemistry (01-01-2017)
    “…Background & Aims: To investigate the expression and prognostic value of α1-ACT (Alpha1-antichymotrypsin) in patients with HCC (hepatocellular carcinoma) and…”
    Get full text
    Journal Article
  7. 7

    Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling by Yin, Lu, Zhou, Liuzhi, Gao, Shiqi, Feng, Yina, Zhu, Hanzhang, Xiang, Jingjing, Xu, Rujun

    Published in Frontiers in molecular biosciences (04-02-2022)
    “…HCC is one of the most common types of malignancies worldwide and the fourth-leading cause of cancer deaths. Thus, there is an urgent need to search for novel…”
    Get full text
    Journal Article
  8. 8

    Selective radical resection for unresectable pancreatic cancer by Jia, Changku, Liu, Ling, Zhu, Hanzhang, Shen, Weimin, Yang, Chunfeng

    Published in Cirugia y cirujanos (01-04-2022)
    “…The objective of the study was to evaluate safety and value of radical resection for unresectable pancreatic cancer (UPC). Clinical data were analyzed…”
    Get full text
    Journal Article
  9. 9

    Selective Radical Resection for Unresectable Pancreatic Cancer by Changku Jia, Ling Liu, Hanzhang Zhu, Weimin Shen, Chunfeng Yang

    Published in BioMedica (31-12-2020)
    “…Background and Objective: For inefficiency of chemotherapy and radiation against pancreatic cancer, resection rate for primary unresectable pancreatic cancer…”
    Get full text
    Journal Article
  10. 10

    Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy by Zhu, Hanzhang, Shan, Yuqiang, Ge, Ke, Lu, Jun, Kong, Wencheng, Jia, Changku

    Published in Cellular oncology (Dordrecht) (01-12-2020)
    “…Background Hepatocellular carcinoma (HCC) is one of the most common and devastating malignancies. Oxaliplatin, a platinum-based chemotherapeutic agent, is…”
    Get full text
    Journal Article
  11. 11

    miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling by Zheng, Sixin, Hu, Lingling, Song, Qingwen, Shan, Yuqiang, Yin, Guang, Zhu, Hanzhang, Kong, Wencheng, Zhou, Chunhua

    Published in Aging (Albany, NY.) (26-12-2021)
    “…In this study, we examined whether and how miR-545 modulates ferroptosis in colorectal cancer (CRC). HT-29 and HCT-116 human CRC cell viability was examined…”
    Get full text
    Journal Article
  12. 12

    Selective Radical Resection for Unresectable Pancreatic Cancer by Changku Jia, Ling Liu, Hanzhang Zhu, Weimin Shen, Chunfeng Yang

    Published in BioMedica (31-12-2020)
    “…Background and Objective: For inefficiency of chemotherapy and radiation against pancreatic cancer, resection rate for primary unresectable pancreatic cancer…”
    Get full text
    Journal Article
  13. 13

    LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p by Zhu, Hanzhang, Shan, Yuqing, Ge, Ke, Lu, Jun, Kong, Wencheng, Jia, Changku

    “…Studies have found that LncRNA CYTOR is an important regulator of cancer. However, the function of lncRNA CYTOR in pancreatic cancer (PC) is unclear. This…”
    Get full text
    Journal Article
  14. 14

    Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME by Zhu, Hanzhang, Ge, Ke, Lu, Jun, Jia, Changku

    “…Hepatocellular carcinoma (HCC) patients have low 5-year survival due to the delayed diagnosis, so it is necessary to develop an alternative treatment…”
    Get full text
    Journal Article
  15. 15

    Light‐activatable multifunctional paclitaxel nanoprodrug for synergistic chemo‐photodynamic therapy in liver cancer by Zhu, Hanzhang, Zhou, Weijiang, Wan, Yafeng, Lu, Jun, Ge, Ke, Jia, Changku

    Published in BioFactors (Oxford) (01-07-2022)
    “…Paclitaxel (Ptx) is widely utilized to treat liver cancer, and the treatment benefit of reactive oxygen species (ROS)‐responsive Ptx nanoprodrug is…”
    Get full text
    Journal Article
  16. 16

    EIF3B promotes cancer progression in pancreatic cancer by Zhu, Hanzhang, Shan, Yuqiang, Ge, Ke, Lu, Jun, Kong, Wencheng, Jia, Changku

    Published in Scandinavian journal of gastroenterology (04-03-2021)
    “…This study aimed to analyze the relative expression of Eukaryotic Translation Initiation Factor 3 Subunit B (EIF3B) in pancreatic cancer and elucidate its…”
    Get full text
    Journal Article
  17. 17